Want to see NUTX full AI Analyst Report?
Clinigence Holdings (NUTX) Stock Statistics & Valuation Metrics
Total Valuation
Clinigence Holdings has a market cap or net worth of $1.37B. The enterprise value is $1.45B.
- Market Cap
- $1.37B
- Enterprise Value
- $1.45B
Share Statistics
Clinigence Holdings has 6,847,973 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 6,847,973
- Owned by Insiders
- 32.76%
- Owned by Institutions
- 25.84%
Financial Efficiency
Clinigence Holdings’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 25.91%.
- Return on Equity (ROE)
- 0.21
- Return on Assets (ROA)
- 0.08
- Return on Invested Capital (ROIC)
- 25.91%
- Return on Capital Employed (ROCE)
- 0.36
- Revenue Per Employee
- 844.03K
- Profits Per Employee
- 68.26K
- Employee Count
- 1,037
- Asset Turnover
- 0.95
- Inventory Turnover
- 150.38
Valuation Ratios
The current PE Ratio of Clinigence Holdings is 7.63. Clinigence Holdings’s PEG ratio is 0.04.
- PE Ratio
- 7.63
- PS Ratio
- 1.62
- PB Ratio
- 3.49
- Price to FCF
- 5.00
- Price to Operating Cash Flow
- 4.92
- PEG Ratio
- 0.04
Income Statement
In the last 12 months, Clinigence Holdings had revenue of 875.26M and earned 70.79M in profits. Earnings per share was 11.13.
- Revenue
- 875.26M
- Gross Profit
- 444.28M
- Operating Income
- 275.63M
- Pretax Income
- 244.78M
- Net Income
- 70.79M
- EBITDA
- 287.54M
- Earnings Per Share (EPS)
- 11.13
Cash Flow
In the last 12 months, operating cash flow was 279.62M and capital expenditures -5.45M, giving a free cash flow of 274.17M billion.
- Operating Cash Flow
- 279.62M
- Free Cash Flow
- 274.17M
- Free Cash Flow per Share
- 39.90
Dividends & Yields
Clinigence Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 20.00%
- Earnings Yield
- 13.08%
Stock Price Statistics
- Beta
- 2.14
- 52-Week Price Change
- 60.76%
- 50-Day Moving Average
- 203.39
- 200-Day Moving Average
- 150.31
- Relative Strength Index (RSI)
- 46.68
- Average Volume (3m)
- 154.57K
Important Dates
Clinigence Holdings upcoming earnings date is Nov 05, 2026, After Close (Not Confirmed).
- Last Earnings Date
- Aug 06, 2026
- Next Earnings Date
- Nov 05, 2026
- Ex-Dividend Date
- ―
Financial Position
Clinigence Holdings as a current ratio of 3.41, with Debt / Equity ratio of 106.66%
- Current Ratio
- 3.41
- Quick Ratio
- 3.39
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- 0.58
- Interest Coverage Ratio
- 12.40
Taxes
In the past 12 months, Clinigence Holdings has paid 64.42M in taxes.
- Income Tax
- 64.42M
- Effective Tax Rate
- 0.26
Enterprise Valuation
Clinigence Holdings EV to EBITDA ratio is 3.94, with an EV/FCF ratio of 5.52.
- EV to Sales
- 1.79
- EV to EBITDA
- 3.94
- EV to Free Cash Flow
- 5.52
- EV to Operating Cash Flow
- 5.41
Balance Sheet
Clinigence Holdings has $205.21M in cash and marketable securities with $347.34M in debt, giving a net cash position of -$142.13M billion.
- Cash & Marketable Securities
- $205.21M
- Total Debt
- $347.34M
- Net Cash
- -$142.13M
- Net Cash Per Share
- -$20.75
- Tangible Book Value Per Share
- $68.81
Margins
Gross margin is 51.26%, with operating margin of 43.02%, and net profit margin of 21.25%.
- Gross Margin
- 51.26%
- Operating Margin
- 43.02%
- Pretax Margin
- 40.57%
- Net Profit Margin
- 21.25%
- EBITDA Margin
- 45.39%
- EBIT Margin
- 42.91%
Analyst Forecast
The average price target for Clinigence Holdings is $295.40, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $295.40
- Price Target Upside
- 47.59% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 5
- Revenue Growth Forecast
- 6.88%
- EPS Growth Forecast
- 155.98%
Scores
- Smart Score
- 10
- AI Score
- 79
